tiprankstipranks
Petros Pharmaceuticals (PTPI)
OTHER OTC:PTPI
US Market
PTPI
Petros Pharmaceuticals
RESEARCH TOOLSreports
Want to see PTPI full AI Analyst Report?

Petros Pharmaceuticals (PTPI) Income Statement

200 Followers

Petros Pharmaceuticals Income Statement

Last quarter (Q4 2025), Petros Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Petros Pharmaceuticals's net income was $1.91B. See Petros Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 5.11M$ 5.82M$ 5.99M$ 7.81M
Gross Profit
$ 0.00$ 3.90M$ 4.19M$ 3.70M$ 6.21M
Operating Expenses
$ 4.64M$ 21.58M$ 17.81M$ 23.62M$ 24.26M
Depreciation and Amortization
$ 0.00$ 2.94M$ 3.42M$ 5.72M$ 6.88M
EBITDA
$ -4.64M$ -10.81M$ -4.21M$ -13.73M$ -1.74M
Operating Income
$ -4.64B$ -17.68M$ -13.62M$ -19.92M$ -18.05M
Other Income/Expenses
$ 141.31M$ 3.36M$ 5.45M$ -121.82K$ 9.06M
Pretax Income
$ -4.50B$ -14.32M$ -8.16M$ -20.04M$ -8.99M
Net Income
$ 1.91B$ -14.32M$ -8.16M$ -20.04M$ -8.99M
Per Share Metrics
Basic EPS
$ 6.82$ -3.34$ -6.35$ -9.68$ -8.25
Diluted EPS
$ 6.82$ -3.34$ -6.35$ -9.68$ -8.25
Weighted Average Shares Outstanding
 280.65M 8.03M 1.29M 2.07M 1.09M
Weighted Average Shares Outstanding (Diluted)
 280.65M 8.03M 2.18M 2.07M 1.09M
Currency in USD

Petros Pharmaceuticals Earnings and Revenue History